
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7126937
[patent_doc_number] => 20050058681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Odorless insect repellant and method of use'
[patent_app_type] => utility
[patent_app_number] => 10/930863
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1872
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10930863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/930863 | Odorless insect repellant and method of use | Aug 31, 2004 | Abandoned |
Array
(
[id] => 4927927
[patent_doc_number] => 20080167290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Combination of a Serotonin Reuptake Inhibitor and Amoxapine'
[patent_app_type] => utility
[patent_app_number] => 10/569346
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4772
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167290.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569346 | Combination of a Serotonin Reuptake Inhibitor and Amoxapine | Aug 31, 2004 | Abandoned |
Array
(
[id] => 5689031
[patent_doc_number] => 20060287346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer'
[patent_app_type] => utility
[patent_app_number] => 10/570335
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4807
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570335 | Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer | Aug 30, 2004 | Abandoned |
Array
(
[id] => 4927986
[patent_doc_number] => 20080167349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Pharmaceutical Product For Injection'
[patent_app_type] => utility
[patent_app_number] => 10/568417
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4331
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167349.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568417 | Pharmaceutical Product For Injection | Aug 18, 2004 | Abandoned |
Array
(
[id] => 5241714
[patent_doc_number] => 20070020206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Use of biotin or a biotin derivative for lightening skin and treating age spots'
[patent_app_type] => utility
[patent_app_number] => 10/569784
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4164
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569784 | Use of biotin or a biotin derivative for lightening skin and treating age spots | Aug 11, 2004 | Abandoned |
Array
(
[id] => 5194427
[patent_doc_number] => 20070082911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Novel use of quinolone antibiotics'
[patent_app_type] => utility
[patent_app_number] => 10/567057
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3278
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082911.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567057 | Use of quinolone antibiotics | Aug 1, 2004 | Issued |
Array
(
[id] => 4880434
[patent_doc_number] => 20080153817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Treatment for Alzheimer\'s Disease and Related Conditions'
[patent_app_type] => utility
[patent_app_number] => 10/566844
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19841
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566844
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566844 | Treatment for Alzheimer's Disease and Related Conditions | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7555529
[patent_doc_number] => 08067430
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-11-29
[patent_title] => 'Anti-HIV activity of the opioid antagonist naloxone'
[patent_app_type] => utility
[patent_app_number] => 10/902471
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3374
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067430.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902471 | Anti-HIV activity of the opioid antagonist naloxone | Jul 28, 2004 | Issued |
Array
(
[id] => 5310869
[patent_doc_number] => 20090018150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => '5-Ht2b Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/564010
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32609
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564010 | 5-Ht2b Receptor Antagonists | Jul 22, 2004 | Abandoned |
Array
(
[id] => 5677442
[patent_doc_number] => 20060182797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Sutained release formulation for venlafaxine hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 10/565322
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7507
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565322
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565322 | Sutained release formulation for venlafaxine hydrochloride | Jul 22, 2004 | Abandoned |
Array
(
[id] => 5101815
[patent_doc_number] => 20070185077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Methods of treating, preventing and inhibiting cancer metastasis and tumor formation'
[patent_app_type] => utility
[patent_app_number] => 10/564945
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19657
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564945 | Methods of treating, preventing and inhibiting cancer metastasis and tumor formation | Jul 14, 2004 | Abandoned |
Array
(
[id] => 5677436
[patent_doc_number] => 20060182791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Transdermaltherapeutic system containing a pramipexol active agent'
[patent_app_type] => utility
[patent_app_number] => 10/564932
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3165
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564932 | Transdermaltherapeutic system containing a pramipexol active agent | Jul 13, 2004 | Abandoned |
Array
(
[id] => 5875373
[patent_doc_number] => 20060167027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability'
[patent_app_type] => utility
[patent_app_number] => 10/563668
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5888
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563668 | Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability | Jul 6, 2004 | Abandoned |
Array
(
[id] => 8675540
[patent_doc_number] => 08383653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'SIR2 regulation'
[patent_app_type] => utility
[patent_app_number] => 10/560676
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13483
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10560676
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560676 | SIR2 regulation | Jun 29, 2004 | Issued |
Array
(
[id] => 5672986
[patent_doc_number] => 20060178341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev)'
[patent_app_type] => utility
[patent_app_number] => 10/561714
[patent_app_country] => US
[patent_app_date] => 2004-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6723
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561714 | Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev) | Jun 22, 2004 | Abandoned |
Array
(
[id] => 5045577
[patent_doc_number] => 20070264250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Composition for Skin-Whitening and Wrinkle-Care'
[patent_app_type] => utility
[patent_app_number] => 11/658136
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4570
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658136
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658136 | Composition for Skin-Whitening and Wrinkle-Care | Jun 9, 2004 | Abandoned |
Array
(
[id] => 5034277
[patent_doc_number] => 20070098816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Pharmaceutical composition containing histone deacetylase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/558208
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6885
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098816.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558208 | Pharmaceutical composition containing histone deacetylase inhibitor | May 25, 2004 | Abandoned |
Array
(
[id] => 5000450
[patent_doc_number] => 20070043084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => '1,2-Diarylimidazoles useful as inhibitors of cox'
[patent_app_type] => utility
[patent_app_number] => 10/555656
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18066
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20070043084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555656 | 1,2-Diarylimidazoles useful as inhibitors of cox | Apr 25, 2004 | Abandoned |
Array
(
[id] => 4728175
[patent_doc_number] => 20080207719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Treatment of Epilepsy'
[patent_app_type] => utility
[patent_app_number] => 10/552892
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1935
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552892 | Treatment of Epilepsy | Apr 7, 2004 | Abandoned |
Array
(
[id] => 7593130
[patent_doc_number] => 07652071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-26
[patent_title] => 'Penetration of active substances into cells and organs'
[patent_app_type] => utility
[patent_app_number] => 10/551882
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7661
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/652/07652071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551882
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551882 | Penetration of active substances into cells and organs | Mar 24, 2004 | Issued |